abstract |
The present invention is a method for determining a condition of a patient's rheumatoid arthritis, or progression of rheumatoid arthritis, or a treatment suitable for a patient with rheumatoid arthritis, comprising the following steps: (A) determining the level of tenascin C in the sample from the patient; and (b) comparing the level of tenascin C determined in step (a) with one or more reference values. provide. Preferably, rheumatoid arthritis refers to erosive rheumatoid arthritis. |